Loading...
Biodesix, Inc.
BDSX•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.45
$0.03(6.80%)
Biodesix, Inc. (BDSX) Financial Performance & Income Statement Overview
Review Biodesix, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
45.30%
↑ 45.30%
Operating Income Growth
16.55%
↑ 16.55%
Net Income Growth
17.67%
↑ 17.67%
Operating Cash Flow Growth
-112.72%
↓ 112.72%
Operating Margin
-43.71%
↓ 43.71%
Gross Margin
78.38%
↑ 78.38%
Net Profit Margin
-54.28%
↓ 54.28%
ROE
-168.32%
↓ 168.32%
ROIC
-44.63%
↓ 44.63%
Biodesix, Inc. (BDSX) Income Statement & Financial Overview
Review Biodesix, Inc.'s (BDSX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $20.43M | $18.15M | $17.93M | $14.82M |
| Cost of Revenue | $4.34M | $4.18M | $3.88M | $3.17M |
| Gross Profit | $16.09M | $13.97M | $14.05M | $11.64M |
| Gross Profit Ratio | $0.79 | $0.77 | $0.78 | $0.79 |
| R&D Expenses | $2.41M | $2.55M | $2.56M | $2.04M |
| SG&A Expenses | $20.22M | $20.02M | $19.66M | $20.56M |
| Operating Expenses | $22.74M | $22.56M | $22.22M | $22.60M |
| Total Costs & Expenses | $27.08M | $26.74M | $26.09M | $25.77M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.75M | $2.04M | $1.94M | $2.53M |
| Depreciation & Amortization | $1.40M | $1.42M | $1.32M | $1.32M |
| EBITDA | -$5.10M | -$6.80M | -$7.55M | -$9.76M |
| EBITDA Ratio | -$0.25 | -$0.37 | -$0.42 | -$0.66 |
| Operating Income | -$6.65M | -$8.59M | -$8.17M | -$10.95M |
| Operating Income Ratio | -$0.33 | -$0.47 | -$0.46 | -$0.74 |
| Other Income/Expenses (Net) | -$1.60M | -$1.67M | -$2.57M | -$2.59M |
| Income Before Tax | -$8.25M | -$10.26M | -$10.81M | -$13.61M |
| Income Before Tax Ratio | -$0.40 | -$0.57 | -$0.60 | -$0.92 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $1.28M |
| Net Income | -$8.25M | -$10.26M | -$10.81M | -$13.61M |
| Net Income Ratio | -$0.40 | -$0.57 | -$0.60 | -$0.92 |
| EPS | -$0.06 | -$0.07 | -$0.09 | -$0.14 |
| Diluted EPS | -$0.06 | -$0.07 | -$0.09 | -$0.14 |
| Weighted Avg Shares Outstanding | $146.60M | $146.30M | $127.17M | $97.17M |
| Weighted Avg Shares Outstanding (Diluted) | $146.60M | $146.30M | $127.17M | $97.17M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan